phencyclidine has been researched along with Parkinson Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, J; Kim, OJ; Kim, SY; Lee, H; Myung, W | 1 |
| Bronstein, JM; Folle, AD; Kwon, D; Paul, KC; Ritz, B; Wu, J; Yu, Y; Zhang, K | 1 |
| Itoh, H; Kitagawa, M; Ooka, T; Watanabe, A | 1 |
| Dugan, T; Ruhf, RC; Smyth, LT; Whitman, NE | 1 |
| Close, SP; Elliott, PJ; Hayes, AG; Marriott, AS; Walsh, DM | 1 |
| Agid, Y; Brice, A; Duyckaerts, C; Hauw, JJ; LeMoal, M; Mayo, W; Ruberg, M; Simon, H | 1 |
| Backlund, EO; Gerhardt, G; Hoffer, B; Lindvall, O; Olson, L; Rose, G; Seiger, A; Strömberg, I | 1 |
7 other study(ies) available for phencyclidine and Parkinson Disease
| Article | Year |
|---|---|
Long-term exposure to particulate air pollution and incidence of Parkinson's disease: A nationwide population-based cohort study in South Korea.
Topics: Air Pollutants; Air Pollution; Cohort Studies; Dust; Environmental Exposure; Humans; Incidence; Male; Middle Aged; Minerals; Parkinson Disease; Particulate Matter | 2022 |
Traffic-related air pollution and Parkinson's disease in central California.
Topics: Air Pollutants; Air Pollution; California; Dust; Environmental Exposure; Humans; Parkinson Disease; Particulate Matter; Traffic-Related Pollution | 2024 |
[A case of bromocriptine-induced interstitial pneumonitis in an iron factory worker exposed to sand dust].
Topics: Bromocriptine; Dust; Environmental Exposure; Humans; Iron; Male; Metallurgy; Middle Aged; Parkinson Disease; Pulmonary Fibrosis | 1989 |
Clinical manganism and exposure to manganese in the production and processing of ferromanganese alloy.
Topics: Air Pollution; Calcium; Central Nervous System Diseases; Diagnosis, Differential; Dust; Edetic Acid; Environmental Exposure; Humans; Iron; Male; Manganese; Maximum Allowable Concentration; Middle Aged; Occupational Diseases; Parkinson Disease; Ventilation | 1973 |
Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Fluphenazine; Glutamates; Glutamic Acid; Male; Microinjections; Parkinson Disease; Phencyclidine; Rats; Receptors, Glutamate; Receptors, Neurotransmitter; Sulpiride | 1990 |
Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Brain Injuries; Choline O-Acetyltransferase; Female; Humans; Hydroxydopamines; Kinetics; Male; Neuromuscular Depolarizing Agents; Oxadiazoles; Oxidopamine; Parkinson Disease; Phencyclidine; Piperidines; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Phencyclidine; Reference Values; Substantia Nigra; Temporal Lobe | 1990 |
Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenal Medulla; Animals; Caudate Nucleus; Chromaffin System; Disease Models, Animal; Dopamine; Humans; Nerve Regeneration; Neurons; Parkinson Disease; Parkinson Disease, Secondary; Phencyclidine; Pyridines; Receptors, Dopamine; Substantia Nigra; Synaptic Transmission | 1987 |